Does non-surgical periodontal therapy improve biomarkers associated with cardiovascular disease? An umbrella review
摘要
The aim of this umbrella review was to synthesize evidence on the effects of non-surgical periodontal therapy (NSPT) on cardiovascular biomarkers in adults with periodontitis.
Materials and methodsSeven databases were searched up to March 2025 (PROSPERO: CRD420250656185). Included studies evaluated the impact of NSPT on cardiovascular biomarkers, including C-reactive protein (CRP), Interleukin-6, Tumor Necrosis Factor-α, lipid profiles (LDL, HDL, total cholesterol, and triglycerides), and vascular function measures (systolic and diastolic blood pressure, and flow-mediated dilation). The GROOVE tool was used to quantify review overlap, AMSTAR2 for methodological quality and GRADE for evidence certainty. Meta-analyses were recalculated using a random-effects model.
ResultsOf 1,525 records screened, 17 systematic reviews met the inclusion criteria. Pooled findings showed NSPT yielded reductions in CRP (–0.58 mg/L; 95% CI: − 0.91 to − 0.25), LDL (–0.10 mmol/L; 95% CI: − 0.17 to − 0.04), and increased HDL (0.03 mmol/L; 95% CI: 0.03 to 0.05), while other markers and vascular measures showed inconsistent and low-certainty results. Most evidence was classified as weak (Class IV) or non-significant due to heterogeneity, high risk of bias, and study overlap.
ConclusionsNSPT is modestly beneficial for CRP, IL-6, HDL, and LDL levels; however, the overall evidence is limited by methodological weaknesses.
Clinical relevanceNSPT may offer small yet clinically meaningful improvements in systemic cardiovascular risk markers in patients with periodontitis. Coordinated medical–dental care, targeted patient education, and timely delivery of NSPT can be pragmatically integrated to support cardiovascular risk reduction.